These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12134738)

  • 41. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
    Lawrence GL; Boyd I; McIntyre PB; Isaacs D
    Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An audit of influenza vaccination rates.
    Byrnes P; Fulton B; Crawford M
    Aust Fam Physician; 2006 Jul; 35(7):551-2. PubMed ID: 16820833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and factors associated with influenza vaccination of persons over 65 years old in Spain (2009-2014).
    Dios-Guerra C; Carmona-Torres JM; López-Soto PJ; Morales-Cané I; Rodríguez-Borrego MA
    Vaccine; 2017 Dec; 35(51):7095-7100. PubMed ID: 29122385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influenza immunization of Dutch general practitioners: vaccination rate and attitudes towards vaccination.
    Opstelten W; van Essen GA; Ballieux MJ; Goudswaard AN
    Vaccine; 2008 Nov; 26(47):5918-21. PubMed ID: 18804133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
    Clothier HJ; Crawford N; Russell MA; Buttery JP
    Euro Surveill; 2017 May; 22(20):. PubMed ID: 28552101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving influenza immunisation coverage in 2000-2001: a baseline survey, review of the evidence and sharing of best practice.
    Furey A; Robinson E; Young Y
    Commun Dis Public Health; 2001 Sep; 4(3):183-7. PubMed ID: 11732357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative trends from 2008/9 to 2011/12 seasons in influenza vaccination coverages among high risk subjects and health care workers in Spain.
    Jiménez-García R; Rodríguez-Rieiro C; Hernandez-Barrera V; Carrasco Garrido P; López de Andres A; Esteban-Vasallo MD; Domínguez-Berjón MF; Astray-Mochales J
    Vaccine; 2014 Jan; 32(3):350-4. PubMed ID: 24269621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do Thai Physicians Recommend Seasonal Influenza Vaccines to Pregnant Women? A Cross-Sectional Survey of Physicians' Perspectives and Practices in Thailand.
    Praphasiri P; Ditsungneon D; Greenbaum A; Dawood FS; Yoocharoen P; Stone DM; Olsen SJ; Lindblade KA; Muangchana C
    PLoS One; 2017; 12(1):e0169221. PubMed ID: 28099486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Pendulum Has Swung: How Do We Ensure a Life Course Approach to Immunisation in Australia?
    Seale H; McFadden K; Dyda A; Kaufman J; Heywood A
    Front Public Health; 2021; 9():801176. PubMed ID: 35186875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of the Community Assessment for Public Health Response (CASPER) method to assess influenza vaccination and activity in Brazos County, Texas.
    Stone K; Akpalu Y; Horney J
    Vaccine; 2018 Sep; 36(40):6001-6006. PubMed ID: 30150165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in prevalence of influenza vaccination and strength of association of factors predicting influenza vaccination over time--results of two population-based surveys.
    Lau JT; Kim JH; Choi KC; Tsui HY; Yang X
    Vaccine; 2007 Nov; 25(49):8279-89. PubMed ID: 17964010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors associated with pneumococcal immunisation among hospitalised elderly persons: a survey of patient's perception, attitude, and knowledge.
    Ridda I; Motbey C; Lam L; Lindley IR; McIntyre PB; Macintyre CR
    Vaccine; 2008 Jan; 26(2):234-40. PubMed ID: 18054818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determinants of non-vaccination against seasonal influenza in Canadian adults: findings from the 2015-2016 Influenza Immunization Coverage Survey.
    Farmanara N; Sherrard L; Dubé È; Gilbert NL
    Can J Public Health; 2018 Jun; 109(3):369-378. PubMed ID: 29981075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7years follow up study.
    Jiménez-Garcia R; Lopez-de-Andres A; Hernandez-Barrera V; Gómez-Campelo P; San Andrés-Rebollo FJ; de Burgos-Lunar C; Cárdenas-Valladolid J; Abánades-Herranz JC; Salinero-Fort MA
    Vaccine; 2017 Jan; 35(1):101-108. PubMed ID: 27890398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review of strategies to enhance the uptake of seasonal influenza vaccination by Australian healthcare workers.
    Stuart MJ
    Commun Dis Intell Q Rep; 2012 Sep; 36(3):E268-76. PubMed ID: 23186238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study.
    Hattingh HL; Sim TF; Parsons R; Czarniak P; Vickery A; Ayadurai S
    BMJ Open; 2016 Sep; 6(9):e011948. PubMed ID: 27650763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providers.
    Biezen R; Grando D; Mazza D; Brijnath B
    Vaccine; 2018 Feb; 36(6):859-865. PubMed ID: 29310901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions.
    Tuckerman J; Misan S; Salih S; Joseph Xavier B; Crawford NW; Lynch J; Marshall HS
    Vaccine; 2018 Dec; 36(52):8138-8147. PubMed ID: 30454947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.